Abstract
The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥65years old had 15.7% greater odds of receiving a generic AED (OR=1.157; 95% CI=1.056–1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR=2.44; CI=2.168–2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR=0.874; CI=0.821–0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
